Evidence map›Paper›PMID 32244343›Full record

ArticleSensors (Basel, Switzerland)2020

Microfluidic Point-of-Care Devices: New Trends and Future Prospects for eHealth Diagnostics.

Jorge Ricardo Mejía-Salazar, Kamilla Rodrigues Cruz, Elsa María Materón Vásques, Osvaldo Novais de Oliveira

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
11.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 211 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Jorge Ricardo Mejía-SalazarNational Institute of Telecommunications (Inatel), 37540-000 Santa Rita do Sapucaí, MG, Brazil.ORCID 0000-0003-1742-9957
Kamilla Rodrigues CruzNational Institute of Telecommunications (Inatel), 37540-000 Santa Rita do Sapucaí, MG, Brazil.
Elsa María Materón VásquesSao Carlos Institute of Physics, University of Sao Paulo, P.O. Box 369, 13560-970 Sao Carlos, SP, Brazil.
Osvaldo Novais de OliveiraSao Carlos Institute of Physics, University of Sao Paulo, P.O. Box 369, 13560-970 Sao Carlos, SP, Brazil.
National Institute of Telecommunications · BRUniversidade de São Paulo · BRUniversidade Federal de São Carlos · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 429496/2018-4; 305958/2018-6Fundação de Amparo à Pesquisa do Estado de São Paulo 2013/14262-7Rede Nacional de Ensino e Pesquisa 01250.075413/2018-04
6 · The paper itself

Abstract

Point-of-care (PoC) diagnostics is promising for early detection of a number of diseases, including cancer, diabetes, and cardiovascular diseases, in addition to serving for monitoring health conditions. To be efficient and cost-effective, portable PoC devices are made with microfluidic technologies, with which laboratory analysis can be made with small-volume samples. Recent years have witnessed considerable progress in this area with "epidermal electronics", including miniaturized wearable diagnosis devices. These wearable devices allow for continuous real-time transmission of biological data to the Internet for further processing and transformation into clinical knowledge. Other approaches include bluetooth and WiFi technology for data transmission from portable (non-wearable) diagnosis devices to cellphones or computers, and then to the Internet for communication with centralized healthcare structures. There are, however, considerable challenges to be faced before PoC devices become routine in the clinical practice. For instance, the implementation of this technology requires integration of detection components with other fluid regulatory elements at the microscale, where fluid-flow properties become increasingly controlled by viscous forces rather than inertial forces. Another challenge is to develop new materials for environmentally friendly, cheap, and portable microfluidic devices. In this review paper, we first revisit the progress made in the last few years and discuss trends and strategies for the fabrication of microfluidic devices. Then, we discuss the challenges in lab-on-a-chip biosensing devices, including colorimetric sensors coupled to smartphones, plasmonic sensors, and electronic tongues. The latter ones use statistical and big data analysis for proper classification. The increasing use of big data and artificial intelligence methods is then commented upon in the context of wearable and handled biosensing platforms for the Internet of things and futuristic healthcare systems.

Indexed as

Biosensing TechniquesArtificial IntelligenceElectronicsHumansMicrofluidicsPoint-of-Care SystemsPoint-of-Care TestingSmartphoneTelemedicineWearable Electronic Devicesartificial intelligencebig databiosensorsInternet-of-thingslab-on-a-chippoint-of-carewearable devices

Identifiers

PMID32244343
PMCPMC7180826
OpenAlexW3014408296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.